|
|
|
|
||
Buy
CompetitionThe U.S. Food and Drug Administration (FDA) has approved a new generic version of Firazyr (icatibant injection), a medication to treat acute swelling attacks in patients with hereditary angioedema (HAE), Glenmark Pharmaceuticals, announced in a press release. According to the India-based company, the newly approved generic will be available in a pre-filled 30 mg/3 mL single-use syringe. It will be manufactured in Glenmark’s North American manufacturing facility in Monroe, North Carolina. |
return to message board, top of board |
Msg # | Subject | Author | Recs | Date Posted |
12735 | Re: Competition | moegrabbedmythumb | 0 | 6/1/2021 12:58:58 PM |